| Browse All

Turn Therapeutics Inc. (TTRX)

Healthcare | Biotechnology | Westlake Village, United States | NasdaqGM
3.40 USD +0.01 (0.444%) ⇧ (April 21, 2026, 3:38 p.m. EDT)

Short-term: ☆☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 18, 2026, 11:28 p.m. EDT

Turn Therapeutics (TTRX) presents a 'Screaming Sell' short-term signal based on a highly confident forecasting model predicting a ~2.4% downside over 45 days, heavily weighted by significant volatility (Ljung-Box p < 0.0001), compounded by deteriorating fundamentals including negative earnings, a negative operating cash flow, and a dangerous current ratio of 0.87; while insider buying offers a generic bullish narrative, the asset lacks financial stability, dividends, and any realistic long-term growth catalyst beyond a distant 2026 drug trial.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.277783
AutoETS0.335217
MSTL0.350864
AutoARIMA0.645808

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 54%
H-stat 1.08
Ljung-Box p 0.000
Jarque-Bera p 0.002
Excess Kurtosis 1.95
Attribute Value
Sector Healthcare
Debt to Equity Ratio 1.715
Market Cap 101,130,392
Forward P/E -22.63
Website https://www.turntherapeutics.com

Info Dump

Attribute Value
52 Week Change -0.5171429
Address1 250 N Westlake Blvd
All Time High 26.5
All Time Low 2.57
Ask 3.53
Ask Size 4
Average Daily Volume10 Day 34,180
Average Daily Volume3 Month 25,901
Average Volume 25,901
Average Volume10Days 34,180
Bid 3.1
Bid Size 3
Book Value 0.018
City Westlake Village
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 3.395
Current Ratio 0.866
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 3.435
Day Low 3.2
Debt To Equity 1.715
Display Name Turn Therapeutics
Earnings Timestamp 1,774,987,200
Earnings Timestamp End 1,778,675,400
Earnings Timestamp Start 1,778,675,400
Ebitda -6,302,850
Ebitda Margins 0.0
Enterprise To Ebitda -15.182
Enterprise Value 95,687,808
Eps Current Year -0.1
Eps Forward -0.15
Eps Trailing Twelve Months -0.12
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 3.4668
Fifty Day Average Change -0.07179999
Fifty Day Average Change Percent -0.02071074
Fifty Two Week Change Percent -51.71429
Fifty Two Week High 26.5
Fifty Two Week High Change -23.105
Fifty Two Week High Change Percent -0.8718868
Fifty Two Week Low 2.57
Fifty Two Week Low Change 0.82500005
Fifty Two Week Low Change Percent 0.3210117
Fifty Two Week Range 2.57 - 26.5
Financial Currency USD
First Trade Date Milliseconds 1,759,930,200,000
Float Shares 11,128,514
Forward Eps -0.15
Forward P E -22.633333
Free Cashflow 1,741,639
Full Exchange Name NasdaqGM
Full Time Employees 2
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Gross Profits -496,948
Has Pre Post Market Data 1
Held Percent Insiders 0.63741
Held Percent Institutions 0.01751
Implied Shares Outstanding 29,788,040
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ipo Expected Date 2,025-10-08
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Long Name Turn Therapeutics Inc.
Market us_market
Market Cap 101,130,392
Market State REGULAR
Max Age 86,400
Message Board Id finmb_590974024
Most Recent Quarter 1,767,139,200
Net Income To Common -3,194,080
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 100,683,575
Number Of Analyst Opinions 1
Open 3.4
Operating Cashflow -2,562,901
Operating Margins 0.0
Payout Ratio 0.0
Phone 818 546 4011
Previous Close 3.38
Price Eps Current Year -33.95
Price Hint 4
Price To Book 188.61111
Profit Margins 0.0
Quick Ratio 0.846
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0149998665
Regular Market Change Percent 0.44378302
Regular Market Day High 3.435
Regular Market Day Low 3.2
Regular Market Day Range 3.2 - 3.435
Regular Market Open 3.4
Regular Market Previous Close 3.38
Regular Market Price 3.395
Regular Market Time 1,776,800,329
Regular Market Volume 14,786
Return On Assets -0.55903
Return On Equity -1.4166701
Sand P52 Week Change 0.34445214
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 29,788,040
Shares Percent Shares Out 0.0021
Shares Short 66,046
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 70,807
Short Name Turn Therapeutics Inc.
Short Ratio 3.27
Source Interval 15
State CA
Symbol TTRX
Target High Price 8.0
Target Low Price 8.0
Target Mean Price 8.0
Target Median Price 8.0
Total Cash 5,076,144
Total Cash Per Share 0.17
Total Debt 80,376
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.12
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.96703
Two Hundred Day Average Change -0.57203007
Two Hundred Day Average Change Percent -0.14419605
Type Disp Equity
Volume 14,786
Website https://www.turntherapeutics.com
Zip 91,362